HOME » News & Media

    Vyome Presents on the Development of DARTs at the 2016 ASM Conference

    13 Dec 2016

    Vyome presents two posters at the American Society of Microbiology’s ASM Conference on Antibacteri...

    View More
    Vyome Presents on Development of DARTs at ASM 2016

    08 Dec 2016

    Vyome Presents on Development of DARTs to Treat Infections Caused by Antibiotic-Resistant Skin Oppor...

    View More
    Vyome Biosciences Administers First In-human Dose of VB 1953

    03 Nov 2016

    Vyome announced that it administered the first in-human dose of its lead candidate VB 1953 in its Ph...

    View More
    Vyome Biosciences Administers First In-human Dose of VB 1953 in U.S. Phase 1 Clinical Study

    31 Oct 2016

    VB 1953 is Vyome Biosciences’ lead program focused on the treatment of antibiotic resistant acne....

    View More
    Crossover investor backs antibiotic-resistant dermatology startup into the clinic

    25 Aug 2016

    Vyome Biosciences closed $14 Mn Series C financing led by Perceptive Advisors...

    View More
    Vyome Biosciences Raises $14M Series C for Acne Drug Trials

    24 Aug 2016

    Vyome Biosciences closed $14 Mn Series C financing led by Perceptive Advisors...

    View More
    Vyome Biosciences raises $14 Mn in Series C funding

    24 Aug 2016

    Vyome Biosciences closed $14 Mn Series C financing led by Perceptive Advisors...

    View More
    Vyome Biosciences gets Rs 93cr in Series C

    24 Aug 2016

    Vyome Biosciences closed $14 Mn Series C financing led by Perceptive Advisors...

    View More
    Vyome Biosciences raises $14mn Series-C funding, to further invest in R&D

    24 Aug 2016

    Vyome Biosciences closed $14 Mn Series C financing led by Perceptive Advisors...

    View More
    Vyome Bioscience to present data at ASM Microbe Conference 2016, Boston.

    15 Jun 2016

    Vyome will present data on its breakthrough technology- MRT, at ASM Microbe Conference 2016...

    View More
    Vyome Biosciences’ IND application receives US FDA approval

    15 Jan 2016

    US Food and Drug Administration (US FDA) has accepted Vyome Biosciences’ Investigational New Drug ...

    View More
    Vyome Bio's Acne Drug IND Application Gets US FDA Nod

    15 Jan 2016

    Bio-pharmaceutical company Vyome Biosciences today said the US Food and Drug Administration (USFDA) ...

    View More
    Vyome Biosciences’ IND application receives US FDA approval

    15 Jan 2016

    Bio-pharmaceutical company Vyome Biosciences today said the US Food and Drug Administration (USFDA) ...

    View More
    USFDA accepts Vyome's Investigational New Drug (IND) Application for VB-1953 for Acne

    06 Jan 2016

    US Food and Drug Administration (USFDA) has accepted Vyome's Investigational New Drug (IND) Applicat...

    View More

    Copyright © 2015 Vyome Biosciences. All rights reserved.